Group A streptococcal antibodies in subjects with or without rheumatic fever in areas with high or low incidences of rheumatic fever

Clinical and Diagnostic Laboratory Immunology

Volumn 10, Issue 5, 2003, Pages 886-890

  Ayoub, Elia M ^a   Nelson, Beverly ^e   Shulman, Stanford T ^f   Barrett, Douglas J ^a   Campbell, J Douglas ^b   Armstrong, George ^c   Lovejoy, John ^d   Angoff, Gerald H ^g   Rockenmacher, Sol ^h  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b University Medical Center ^*  (United States)

^c WOLFSON CHILDREN S HOSPITAL   (United States)

^d St Luke's Hospital   (United States)

^e Ministry of Health   (Grenada)

^f NORTHWESTERN UNIVERSITY   (United States)

^g New England Heart Institute   (United States)

^h DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISTREPTOLYSIN; BACTERIUM ANTIBODY; CARBOHYDRATE; DEOXYRIBONUCLEASE; STREPTOLYSIN O;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; BACTERIAL CELL WALL; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; INCIDENCE; PREVALENCE; PRIORITY JOURNAL; RHEUMATIC FEVER; STREPTOCOCCUS GROUP A; STREPTOCOCCUS INFECTION; UNITED STATES;

ADOLESCENT; ANTIBODIES, BACTERIAL; CHILD; CHILD, PRESCHOOL; FLORIDA; GRENADA; HUMANS; RHEUMATIC FEVER; STREPTOCOCCUS PYOGENES;

EID: 0141675190     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.10.5.886-890.2003     Document Type: Article

References (19)

1. Appleton, R. S., B. E. Victorica, and E. M. Ayoub. 1985. Specificity of persistence of antibody to the streptococcal group A carbohydrate in rheumatic valvular heart disease. J. Lab. Clin. Med. 105:114-119.
2. Ayoub, E. M., M. Kotb, and M. W. Cunningham. 2000. Rheumatic fever pathogenesis, p. 102-132. In D. L. Stevens and E. L. Kaplan (ed.), Streptococcal infections: clinical aspects, microbiology, and molecular pathogenesis. Oxford University Press, Inc., New York, N.Y.
3. Ayoub, E. M. 1991. Immune response to group A streptococcal infections. Pediatr. Infect. Dis. J. 10(Suppl.):S15-S19.
4. Ayoub, E. M., and E. Harden. 1997. Immune response to streptococcal antigens: diagnostic methods, p. 450-457. In N. R. Rose, E. Conway de Macario, J. D. Folds, H. C. Lane, and R. M. Nakamura (ed.), Manual of clinical laboratory immunology, 5th ed. American Society for Microbiology, Washington, D.C.
5. Ayoub, E. M., and L. W. Wannamaker. 1962. Evaluation of the streptococcal deoxyribonuclease B and diphosphopyridine nucleotidase antibody tests in acute rheumatic fever and acute glomerulonephritis. Pediatrics 29:527-538.
6. Children's Medical Services, Department of Health, State of Florida. 1997. Rheumatic fever prophylaxis program in Florida. Rheumatic Fever Registry of the State of Florida, Tallahassee, Fla.
7. Dajani, A. S., E. M. Ayoub, F. Z. Bierman, A. L. Bisno, F. W. Denny, D. T. Durack, P. Ferrieri, M. Freed, M. Gerber, E. L. Kaplan, A. W. Karchmer, M. Markowitz, S. H. Rahimtoola, S. T. Shulman, G. Stollerman, T. Masato, A. Taranta, K. A. Taubert, and W. Wilson. 1992. Guidelines for the diagnosis of rheumatic fever: Jones Criteria, updated 1992. JAMA 87:302-307.
8. Dudding, B. A., and E. M. Ayoub. 1968. Persistence of streptococcal group A antibody in patients with rheumatic valvular disease. J. Exp. Med. 128:1081-1098.
9. Kaplan, E. L., C. D. Rothermel, and D. R. Johnson. 1998. Antistreptolysin O and anti-deoxyribonuclease B titers: normal values for children ages 2 to 12 in the United States. Pediatrics 101:86-88.
10. Kaplan, E. L., B. F. Anthony, S. S. Chapman, E. M. Ayoub, and L. W. Wannamaker. 1970. The influence of the site of infection on the immune response to group A streptococci. J. Clin. Invest. 49:1405-1414.
11. Markowitz, M. 1985. The decline of rheumatic fever: role of medical intervention. The Lewis W. Wannamaker Memorial Lecture. J. Pediatr. 106:545-550.
12. Meiselas, L. E., S. B. Zinglae, S. L. Lee, et al. 1961. Antibody production in rheumatic diseases: the effect of brucella antigen. J. Clin. Investig. 40:1872-1881.
13. Ministry of Health of Grenada. 1998. Data on the incidence of rheumatic fever in Grenada. Rheumatic Fever Register. Ministry of Health, St. George's, Grenada.
14. Rejholec, V. 1957. Incidence of rheumatic fever in relation to immunologic reactivity. Ann. Rheum. Dis. 16:23-30.
15. Shulman, S. T., E. M. Ayoub, and B. E. Victorica. 1974. Differences in antibody response to streptococcal antigens in children with rheumatic and non-rheumatic mitral valve disease. Circulation 50:1244-1251.
16. Stollerman, G. H. 1972. Hypersensitivity and antibody responses in streptococcal disease, p. 501-513. In L. M. Wannamaker and J. M. Matsen (ed.), Streptococci and streptococcal diseases: recognition, understanding, and management. Academic Press, New York, N.Y.
17. Swift, H. F. 1929. Rheumatic fever. JAMA 92:2071-2083.
18. Urdahl, K. B., J. D. Matthews, and B. Currie. 2002. Anti-streptokinase antibodies and streptokinase resistance in an Aboriginal population in northern Australia. Aust. N. Z. J. Med. 26:49-53.
19. Wannamaker, L. W., and E. M. Ayoub. 1960. Antibody titers in acute rheumatic fever. Circulation 21:598-614.